Mayo Petersen News Today

In total, 22 dolphin brains were studied in which researchers noted that the animals presented alterations in their brain chemistry, changes most commonly found in humans who have Alzheimer's.

SAN FRANCISCO, United States (AP) — An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening — but the anxiously awaited new data leaves unclear how much differenc...

Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better treatments of the incurable disease.

An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening — but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives.

Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study

Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study

Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study

Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study

Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study

Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study